Michael Palestine, MD
Infectious Disease · Santa Fe, NMNPI 1811935208
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Viiv Healthcare Company at 50.0% of the total. That places this record below the midpoint for infectious disease clinicians in NM, where the typical reported total is $404.
Across 12 payments — averaging $33.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$202
- Gilead$87
- AbbVie$45
- Merck$35
- Insmed, Inc.$21
- Tactile Systems Technology Inc$14
Across 19 payments — averaging $2367.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cue Health Inc.$31K
- Gilead$12K
- GSK$2K
What the payments were for
- Food & beverage$404100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 5 | $202 |
| Gilead | 1 | $87 |
| AbbVie | 2 | $45 |
| Merck | 2 | $35 |
| Insmed, Inc. | 1 | $21 |
| Tactile Systems Technology Inc | 1 | $14 |
How this compares
$404 in reported general payments places this provider in the 50th percentile of 31 infectious disease providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Itraconazole | 11 | $1,012 |
| Doxycycline Hyclate | 13 | $361 |
| Amoxicillin | 14 | $145 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Santa Fe
- Joel GallantSanta Fe$18K
- Joshua Hawley-MolloySanta Fe$598
- Cathy PettiAlbuquerque$29K
- Obiefuna OkoliLas Cruces$12K
- Jeffrey RossAlbuquerque$5K
- Thomas RobertsAlbuquerque$5K
- Mohamed Al KatebAlbuquerque$2K
- Felix CernaAlbuquerque$2K
- Jorge Soria MoncadaAlbuquerque$2K
- David StrykerAlbuquerque$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.